Latest 8-K filings

Replimune Group, Inc. presented data on RP1 (vusolimogene oderparepvec) in combination with nivolumab for advanced melanoma to the FDA's Advisory Committee.

Piper Sandler Companies announced robust second quarter 2026 financial results, with net revenues surging 25% year-over-year to $496 million, driven by strong performance in advisory services.

Vericel Corporation announced robust second quarter 2026 financial results, exceeding expectations with a 22% revenue increase and raising full-year guidance, alongside a new $200 million share repurchase program.

BGC Group announced record second quarter revenues of $845.5 million, an 8% increase year-over-year, driven by broad-based growth across all asset classes.

UFP Industries presents its Q2 2026 investor relations update, detailing performance, strategies, and outlook across its construction, packaging, and retail solutions segments.

The Marcus Corporation announced robust financial results for its second quarter fiscal 2026, with significant increases in revenue, operating income, net earnings, and Adjusted EBITDA, driven by strong performance in both its theatre and hotel divisions.

Evommune, Inc. has dosed the first patient in its Phase 2b clinical trial for EVO756, an MRGPRX2 inhibitor, for migraine prophylaxis, with top-line data expected in 2027.

Freddie Mac announced a net income of $3.8 billion for the second quarter of 2026, a 61% increase year-over-year, driven by a credit reserve release and strong revenues.

IDACORP, Inc. announced robust second quarter 2026 financial results, driven by customer growth and rate changes, leading to an increase in its full-year earnings guidance.

Forum Markets, through its subsidiary Eurus Aerospace Token I LLC, has acquired a CFM56-7B aircraft engine for $11.65 million and immediately leased it out.

Belden Inc. announced record second quarter 2026 financial results, driven by robust demand and the recent acquisition of RUCKUS Networks, positioning the company for continued growth.

Euronet Worldwide announced second quarter 2026 financial results, with revenue up 3% year-over-year, driven by digital accelerators, while adjusted EPS grew 10%.

Sirius XM Holdings announced robust second quarter 2026 results, with revenue up 1% to $2.16 billion and net income soaring 17% to $239 million, prompting an increase in full-year financial guidance.

Civeo Corporation announced its second quarter 2026 financial results, reporting $180.0 million in revenues and a net loss of $2.5 million, while also successfully issuing $115.0 million in convertible senior notes.

MarketAxess Holdings Inc. reported Q2 2026 financial results showing flat total revenues year-over-year, with growth in services and international markets offsetting declines in U.S. credit, as the company prepares for acquisition by Intercontinental Exchange.

Saia, Inc. announced robust second quarter 2026 financial results, showcasing a significant increase in revenue and operating income, alongside improved operational efficiency.

Intercontinental Exchange announces definitive agreement to acquire MarketAxess Holdings Inc. for $167 per share in cash, creating a premier fixed income marketplace.

Winchester Bancorp, Inc. announced fiscal 2026 financial results, reporting a significant net income increase and substantial loan and deposit growth, alongside a strategic shift in its fiscal year-end.

Sphere Entertainment Co. reported a 11% increase in Q2 2026 revenue to $313.6 million, driven by its Sphere segment, despite an overall operating loss.

Wave Life Sciences announced Q2 2026 financial results, highlighting progress in its obesity, AATD, and PNPLA3 liver disease programs, with a strong cash position extending runway into Q3 2028.

LKQ Corporation reported Q2 2026 results with revenue down 3.0% year-over-year, impacted by Europe, while North America showed positive organic growth.

APi Group Corporation announced record second quarter 2026 financial results, exceeding prior year performance with significant revenue growth and improved profitability, leading to an upward revision of full-year financial guidance.

Crescent Biopharma announced Q2 2026 financial results, highlighting progress in its clinical trials for CR-001, CR-002, and CR-003, and a strengthened cash position extending runway into late 2028.

PHINIA Inc. announced its second quarter 2026 financial results, highlighting a 5.6% increase in net sales to $940 million and a definitive agreement to acquire the stoba Group.

Intercontinental Exchange announces definitive agreement to acquire MarketAxess Holdings Inc. for $167 per share in cash, creating a premier fixed income marketplace.

Netlist, Inc. announced significant financial improvements for its second quarter of 2026, with net sales soaring 163% year-over-year and a notable shift from net loss to net income.

Acadian Asset Management Inc. announced significant year-over-year growth in its second quarter 2026 financial and operating results, driven by record management fees and substantial increases in net income and earnings per share.

HNI Corporation announced second quarter 2026 financial results, with non-GAAP diluted EPS of $1.27, a 14% year-over-year increase, and an improved outlook for the full year.

Jones Lang LaSalle Incorporated announced a record second quarter with diluted EPS soaring 100% year-over-year to $4.59, driven by strong performance across Advisory and Capital Markets services.

Tvardi Therapeutics has chosen ulcerative colitis as the initial indication for its STAT3 inhibitor, TTI-109, following promising Phase 1 study results.